Insider Selling: NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Sells $68,253.60 in Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt sold 85,317 shares of the business’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total transaction of $68,253.60. Following the transaction, the insider directly owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. This represents a 60.99% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt bought 27,993 shares of NewGenIvf Group stock. The shares were purchased at an average cost of $0.92 per share, with a total value of $25,753.56.
• On Friday, May 22nd, Financial Lp Hrt bought 137,541 shares of NewGenIvf Group stock. The shares were purchased at an average cost of $0.99 per share, with a total value of $136,165.59.

NewGenIvf Group Trading Down 11.7%

NewGenIvf Group stock opened at $0.91 on Friday. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. NewGenIvf Group Limited has a fifty-two week low of $0.72 and a fifty-two week high of $1,839.00. The firm has a fifty day moving average price of $1.65 and a two-hundred day moving average price of $6.70.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The firm had revenue of $1.42 million for the quarter. On average, research analysts anticipate that NewGenIvf Group Limited will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.